| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |